Search Results
Results found for "G protein-coupled receptors"
- Identification of hub genes in the subacute spinal cord injury in rats
correlation network analysis (WGCNA) were performed using R software, and functional enrichment analysis and protein–protein
- GPCR Drug Discovery Summit 2026: What to Expect in Boston — and How to Register
Kainova Therapeutics presenting Phase 1 outcomes for their EP4 receptor antagonist in solid tumors. With a PhD studying histamine receptors and a postdoc with Bob Lefkowitz at Duke, he brings two decades Therapeutics, a small biotech on the University of Wisconsin–Milwaukee campus working primarily on protease-activated receptors.
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
For GPCR-focused programs, the ability to visualize receptor localization, internalization kinetics, The resulting multiparametric datasets are well-suited for GPCR research, where receptor trafficking, For GPCR assay developers, HCS supports: Quantitative visualization of receptor internalization and Their ability to visualize ligand–receptor interactions directly in living cells produces data that are advantages include: Physiological Relevance Fluorescent ligand binding occurs in intact cells, preserving receptor
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
will focus on the application of artificial intelligence (AI), machine learning, and the design of protein of Oxford, where she is currently Professor of Structural Bioinformatics and leads the University’s Protein
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
47th Symposium on Hormones & Cell Regulation; new approach to GPCR internalization analysis; “Soluble Proteins Target protected agonism: Internalized MT2 signaling escapes AGRP antagonism—unlike α-MSH. Dual-label specificity blocks promiscuous ligand confusion Lanthanide donors + d2 acceptors = high SNR
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientist’s Mission
He’s focused on RGS proteins , pain comorbidities like addiction and depression, and pushing for more
- Signals in Motion: Pain, Metabolism & Terry’s Corner
It will bridge foundational receptor theory with today’s most pressing pharmacological questions, from Kenakin Four decades of receptor theory now fit in one expert-guided hub.
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
ATP and sugar monophosphates and the identification of a novel allosteric site on the vasopressin V2 receptor Discover how factors like restricted tissue diffusion and receptor density can dramatically alter drug Learn how fentanyl slows inhalation via opioid receptors, while xylazine prolongs exhalation through alpha-2 adrenergic receptors, creating a synergistic effect that drives overdose deaths.
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
In this session, you’ll gain: ✅ A clear breakdown of how intracellular vs. extracellular receptor access In this protected environment, pharmacokinetics can decouple from plasma clearance. GPCRs Aren’t Just Surface Receptors Anymore From β2-adrenoreceptors to CCRs and dopamine receptors, multiple
- What If Your Data is Lying to You? The Calcium Assay Dilemma
Revered for its convenience, the FLIPR assay provides rapid insights into receptor activity.
- Community guidelines for GPCR ligand bias: IUPHAR review 32
Depending on which ligand activates a receptor, it can engage different intracellular transducers. 'biased signalling' paradigm requires that we now characterize physiological signalling not just by receptors but by ligand-receptor pairs. The guidelines will aid consistency and clarity, as the basic receptor research and drug discovery communities
- Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response
trisphosphate, which are downstream signal transducers for the expression of fetal genes, increased protein
- From Pipettes to Platforms: The Evolution of GPCR Research
Reading those first papers on GPCR signaling organization absolutely fascinated me — the idea that receptors to integrated signaling landscapes, accelerating drug discovery timelines and expanding targetable receptor
- How GPCR Spatial Signaling Sparked a Scientific Journey
Her early work didn’t involve groundbreaking receptor models or million-dollar grants. within the Drug Discovery Biology theme at Monash Institute of Pharmaceutical Sciences, exploring how receptors
- A broad look into the future of systemic sclerosis
Abs against the angiotensin II receptor subtype 1 (AT1R) and the endothelin receptor type A (ETAR) are Promising nuclear receptors as key regulators of transcriptional programmes will be introduced as well
- Five GPCR Masterclasses Before The Summer
Five sessions examining GPCR science past the equilibrium snapshots, where and when receptors signal,
- How GPCR Collaboration Built an Innovation Engine
flipped that logic: Shared infrastructure, not duplicated equipment Centralized core facilities for receptor That gave them capabilities others couldn’t match — from receptor biosensor platforms to live-cell imaging
- Neurotransmitters: Potential Targets in Glioblastoma
By targeting the receptors synaptically or non-synaptically, neurotransmitters activate multiple signaling Significantly, many ligands acting on neurotransmitter receptors have shown great potential for inhibiting
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
tagging to scalable multiplex assays, this conversation dives deep into the tools now transforming receptor
- Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals
Dopamine receptors are involved in the modulation of fundamental physiological functions, and dysregulation We demonstrate that azodopa activates D1-like receptors in vitro in a light-dependent manner.
- Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late
. ✅ Future-proof your career: Conquer complex laws and understand where receptor theory is going next
- Regulation of pulmonary surfactant by the adhesion GPCR GPR116/ADGRF5 requires a tethered agonist...
upstream of the agonistic peptide sequence, an event necessary for NTF displacement and subsequent receptor phenocopies the pulmonary phenotype of GPR116 knock-out mice, demonstrating that tethered agonist-mediated receptor
- OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
yesterday for contributions to the field of mass spectrometry and establishing it as method to analyse proteins
- First in Human: Early-stage COVID therapies hold promise against omicron variant
partner GlaxoSmithKline PLC posted results Dec. 7 demonstrating activity against the omicron spike protein
- Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
Glutamate exerts its effect through ionotropic and metabotropic glutamate receptors (mGluRs). mGluR2 drug targets for the treatment of many neurological conditions and several compounds targeting these receptors
- The Five Traps of Ignoring Kinetics
offset rate, using rapid calcium assays Potency Is a Ratio of Rates Two ligands compete for the same receptor monophasic curves, you’ll see biphasic signatures or sequential shifts—first cholinesterase inhibition, then receptor
- CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via...
behavior of salivary adenoid cystic carcinoma via the PI3K/AKT signaling pathway "Background CC chemokine receptor 9 (CCR9), an organ-specific chemokine receptor, interacts with its exclusive ligand CCL25 to promote
- Engineered synaptic tools reveal localized cAMP signaling in synapse assembly
We show that locally restricted suppression of postsynaptic cAMP levels or of cAMP-dependent protein-kinase
- Chronic itch: emerging treatments following new research concepts
Current progress in our knowledge of the itch processing, the numerous mediators and receptors involved Currently, inhibitors of IL-31, IL-4/13, NK1 receptors, opioids and cannabinoids, JAK, PDE4 or TRP are
- SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
trust us in the generation of their monoclonal antibodies against small molecules and transmembrane receptors
















